Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.008 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.087 | 0.009 |
mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |